Novel pyrimidine-2,4-diamine derivative suppresses the cell viability and spindle assembly checkpoint activity by targeting Aurora kinases

Author： Salmela Anna-Leena   Pouwels Jeroen   Mäki-Jouppila Jenni   Kohonen Pekka   Toivonen Pauliina   Kallio Lila   Kallio Marko  

Publisher： Oxford University Press

ISSN： 1460-2180

Source： Carcinogenesis, Vol.34, Iss.2, 2013-02, pp. : 436-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Based Design of Novel Anti-Cancer Agents TargetingAurora Kinases

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 1, 2003-01 ,pp. : 25-34

Bentham Science Publishers

Access to resources Recommend Favorite

Nilotinib: a phenylamino-pyrimidine derivative with activity against BCR-ABL, KIT and PDGFR kinases

By Quintáás-Cardama Alfonso   Cortes Jorge  

Future Oncology, Vol. 4, Iss. 5, 2008-10 ,pp. : 611-621

Future Medicine

Access to resources Recommend Favorite

miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer

By Xu Chun   Li Sen   Chen Tengfei   Hu Haibo   Ding Cheng   Xu Zhenlei   Chen Jun   Liu Zeyi   Lei Zhe   Zhang Hong-Tao   Li Chang   Zhao Jun  

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 497-503

Spandidos Publications

Access to resources Recommend Favorite

Aurora A and B Kinases - Targets of Novel Anticancer Drugs

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 219-241

Bentham Science Publishers

Access to resources Recommend Favorite

The Aurora kinases: Role in cell transformation and tumorigenesis

By Katayama H.  

Cancer and Metastasis Reviews, Vol. 22, Iss. 4, 2003-12 ,pp. : 451-464

Springer Publishing Company

Access to resources Recommend Favorite